Thus, the detection of EpCAM+ MPs by flow cytometry showed a better specificity and sensitivity than by ELISA (Sp: 96% vs 89%; Se: 79% vs 66%) to distinguish between carcinoma and non-carcinoma MPE. This evidence concerns the gene EPCAM and carcinoma.